Kuzel T - Search Results

1

Advancements in unresectable melanoma: a multidisciplinary perspective.

Malecek MK, Robinson JK, Bilimoria K, Choi JN, Choi J, Gerami P, Kruser T, Kuzel T, Martini M, Strauss JB, Wayne J, Sosman J, Chandra S. Malecek MK, et al. Among authors: kuzel t. Melanoma Manag. 2016 Sep;3(3):171-175. doi: 10.2217/mmt-2016-0003. Epub 2016 Aug 16. Melanoma Manag. 2016. PMID: 30190886 Free PMC article. No abstract available.

2

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.

Stadler WM, Kuzel T, Shapiro C, Sosman J, Clark J, Vogelzang NJ. Stadler WM, et al. Among authors: kuzel t. J Clin Oncol. 1999 Aug;17(8):2541-5. doi: 10.1200/JCO.1999.17.8.2541. J Clin Oncol. 1999. PMID: 10561320 Clinical Trial.

3

Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.

Gerami P, Wickless SC, Rosen S, Kuzel TM, Ciurea A, Havey J, Guitart J. Gerami P, et al. J Am Acad Dermatol. 2008 Aug;59(2):245-54. doi: 10.1016/j.jaad.2008.04.012. Epub 2008 May 16. J Am Acad Dermatol. 2008. PMID: 18486274

4

Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.

Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J. Gerami P, et al. Among authors: kuzel t. Arch Dermatol. 2008 Jun;144(6):738-46. doi: 10.1001/archderm.144.6.738. Arch Dermatol. 2008. PMID: 18559762

5

Cyclin D1 homogeneous staining regions by fluorescent in situ hybridization: a possible indicator of aggressive behavior in melanomas.

Gerami P, Guitart J, Martini M, Wayne JD, Kuzel T. Gerami P, et al. Among authors: kuzel t. Arch Dermatol. 2008 Sep;144(9):1235-6. doi: 10.1001/archderm.144.9.1235-b. Arch Dermatol. 2008. PMID: 18794480 No abstract available.

6

Interleukins in the treatment of mycosis fungoides.

Gerami P, Guitart J, Rosen S, Kuzel TM. Gerami P, et al. Among authors: kuzel tm. G Ital Dermatol Venereol. 2008 Feb;143(1):55-8. G Ital Dermatol Venereol. 2008. PMID: 18833051 Review.

7

Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center.

Querfeld C, Mehta N, Rosen ST, Guitart J, Rademaker A, Gerami P, Kuzel TM. Querfeld C, et al. Among authors: kuzel tm. Leuk Lymphoma. 2009 Dec;50(12):1969-76. doi: 10.3109/10428190903216770. Leuk Lymphoma. 2009. PMID: 19860617 Clinical Trial.

8

Cutaneous involvement with marginal zone lymphoma.

Gerami P, Wickless SC, Querfeld C, Rosen ST, Kuzel TM, Guitart J. Gerami P, et al. Among authors: kuzel tm. J Am Acad Dermatol. 2010 Jul;63(1):142-5. doi: 10.1016/j.jaad.2009.07.047. Epub 2010 May 11. J Am Acad Dermatol. 2010. PMID: 20462658

9

In situ photoimmunotherapy: a surgery- and limb-sparing approach to the treatment of cutaneous metastases in advanced melanoma.

St Pierre SA, Rommel J, Ciurea A, Fife D, Yoo SS, Martini M, Kuzel TM, Wayne J, Rademaker A, West DP, Alam M. St Pierre SA, et al. Arch Dermatol. 2010 Aug;146(8):831-4. doi: 10.1001/archdermatol.2010.181. Arch Dermatol. 2010. PMID: 20713811 No abstract available.

10

High incidence of gastrointestinal tract disorders and autoimmunity in primary cutaneous marginal zone B-cell lymphomas.

Guitart J, Deonizio J, Bloom T, Martinez-Escala ME, Kuzel TM, Gerami P, Kwasny M, Rosen ST. Guitart J, et al. Among authors: kuzel tm. JAMA Dermatol. 2014 Apr;150(4):412-8. doi: 10.1001/jamadermatol.2013.9223. JAMA Dermatol. 2014. PMID: 24500411

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page